Buckley Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,700
Closed -$295K 142
2019
Q2
$295K Hold
2,700
0.14% 126
2019
Q1
$302K Hold
2,700
0.14% 118
2018
Q4
$260K Hold
2,700
0.13% 126
2018
Q3
$329K Hold
2,700
0.14% 127
2018
Q2
$297K Hold
2,700
0.14% 133
2018
Q1
$288K Hold
2,700
0.14% 136
2017
Q4
$288K Buy
+2,700
New +$289K 0.14% 136

Other funds holding IBB

Buckley Wealth Management's IBB Position: Q3 2019 in Review

Buckley Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,700 shares — an estimated $295K sold.

Buckley Wealth Management first reported a position in IBB in Q4 2017 and held it in 7 quarters. The position peaked at $329K in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Buckley Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Buckley Wealth Management sold 2,700 iShares Biotechnology ETF shares in Q3 2019, an estimated $295K.
  • Buckley Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 7 quarters.
  • Buckley Wealth Management's iShares Biotechnology ETF position peaked at $329K in Q3 2018.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Buckley Wealth Management's 13F filing for Q3 2019, filed 11 Oct 2019.